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Abstract
Background
Data are sparse on the range of BMI among patients acutely admitted to general hospitals.
We investigated BMI values and associated patient characteristics, reasons for hospital
admission, and mortality in Denmark.
Methods
We identified all persons with an acute inpatient admission 2011–2014 in Central Denmark
Region and assessed BMI measurements recorded in the Clinical Information System. We
used cross-sectional and cohort analyses to examine the BMI distribution and its associa-
tion with demographic characteristics, comorbidities, medication use, tobacco smoking, rea-
sons for admission, and 30-day mortality.
Results
Among 92,027 acutely admitted patients (median age 62 years, 49% female) with a BMI
measurement, 4% had a BMI (kg/m2) <18.5, 42% a BMI between 18.5 and 25, 34% a BMI
between 25 and 30, and 20% a BMI30. Compared with normal-weight patients, 30-day
mortality was high among patients with BMI <18.5 (7.5% vs. 2.8%, age- and smoking-
adjusted odds ratio (aOR) 2.4; 95% confidence interval (CI): 2.0–2.9, whereas patients with
overweight (aOR 0.7; 95% CI: 0.6–0.8) and obesity class I (aOR 0.8; 95% CI: 0.6–0.9)).
Compared with the total population, patients with BMI <18.5 were older (68 years median);
more were female (73%); more had comorbidities (Charlson Comorbidity Index score >0 in
42% vs. 33% overall), more were current smokers (45% vs. 27% overall), and acute admis-
sions due to respiratory diseases or femoral fractures were frequent. In contrast, patients
with BMI30 were relatively young (59 years median), fewer smoked (24%): type 2 diabe-
tes, sleep disorders, cholelithiasis, and heart failure were frequent diagnoses. Prevalence of
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therapies for metabolic syndrome, pain, and psychiatric disorders increased with higher
BMI, while patients with BMI <18.5 frequently used asthma medications, glucocorticoids,
and antibiotics.
Conclusion
In patients acutely admitted to general hospitals, reasons for hospital admission and associ-
ated clinical characteristics differ substantially according to BMI range. BMI <18.5 is a clini-
cal predictor of high short-term mortality.
Introduction
Both a low Body Mass Index (BMI) (<18.5 kg/m2, underweight) and a high BMI (30 kg/
m2, obesity) are risk factors for increased morbidity, mortality, and adverse outcome of
many diseases in the general population.[1–5] Despite that, knowledge is sparse on BMI val-
ues in patients acutely admitted to general hospitals, and on clinical characteristics and out-
comes associated with different BMI levels. Earlier studies have suggested a protective effect
of overweight or moderate obesity in patients acutely admitted to hospital with heart failure,
hip fracture, or sepsis–the so-called obesity paradox.[6–11] In general population studies,
newer meta-analyses have challenged the presence of any obesity paradox[5,12] suggesting
that previous findings have been biased by differences in clinical and lifestyle characteristics
associated with different BMI ranges.[13] In general patient populations, such data are
scarce.
Large-scale electronic patient data from clinical information systems constitute a potentially
valuable and cost-efficient method of collecting data on patients’ BMI, both for health care
quality monitoring and for prognostic epidemiological research.[14] Studies have discussed
the potential of using electronic health records, finding great opportunities of investigating dis-
ease development and treatment using electronic health records.[15–17] The Central Den-
mark Region Clinical Information System (CDRCIS) contains readily available data on BMI
covering the entire hospital population in the Region, with virtually complete patient follow-
up.[18]
In the present study, we aimed to examine BMI among patients acutely admitted to general
hospitals and the association of BMI with 30-day mortality. We also examined characteristics
associated with different BMI levels, including demographic characteristics, comorbidities,
medication use, tobacco smoking, and reasons for admission.
Methods
The Central Denmark Region has a mixed rural and urban population of approximately 1.27
million persons. In Denmark, medical records of individual patients are tracked using civil
personal registration numbers. These unique identifiers, encoding sex and date of birth, have
been assigned to all Danish residents since 1968. In the present study, we used civil personal
registration numbers to link data from the Danish National Patient Registry (DNPR),[14] the
Civil Registration System (CRS),[18] the CDRCIS, and the Aarhus University Prescription
Database (AUPD).[19]
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Study population
We used the DNPR to identify all individuals aged> = 18 years in the Central Denmark
Region with one or more acute inpatient hospital admissions recorded between January 1,
2011 and December 31, 2014 (N = 242,637). We then identified all patients with a body mass
index (BMI) measurement in the CDRCIS recorded during their first acute hospital admission
in the study period (N = 92,027, 38%). We grouped these BMI measurement according to stan-
dard categories: underweight (<18.5 kg/m2), normal weight (18.5 to<25 kg/m2), overweight
(25 to<30 kg/m2), obesity class I (30 to<35 kg/m2), obesity class II (35 to<40 kg/m2), and
obesity class III (40 kg/m2).
30-day mortality
We ascertained complete 30-day mortality data from the Danish CRS system.[18]
Reason for hospital admission
In each BMI category, we used the primary (first-listed) discharge diagnosis code recorded in
the DNPR to identify the main reason for the first acute inpatient admission during the study
period. We then examined 10 primary International Classification of Diseases, Tenth Revision
(ICD-10) diagnoses that have been commonly related to either high or low BMI in the litera-
ture: femur fracture[20,21] abdominal pain, angina,[22] atrial fibrillation,[23] pneumonia,
[24,25] chronic obstructive pulmonary disease [COPD], [5,26,27] type 2 diabetes [T2D],[28]
erysipelas,[29,30] cholelithiasis,[31] and sleep disturbances [32] (see S1 Table for codes). Sec-
ond, we grouped patients according to major disease categories in ICD-10 (S1 Table).
Comorbidity
Based on DNPR data, we summarized each patient’s comorbidity history based on hospital
contacts during the five years prior to the admission date, according to 19 disease categories
included in the Charlson Comorbidity Index (CCI).[33] We grouped patients by overall level
of comorbidity, defined as a CCI score of 0 (no comorbidity recorded), 1–2 (moderate comor-
bidity), and 3+ (severe comorbidity) (see S3 and S4 Tables).
Smoking
We used data from the CDRCIS to categorize patients’ tobacco smoking status on the hospital
admission date as follows: no smoking, current smoking, former smoking, or occasional
smoking.
Medication use
We obtained individual-level information from the AUPD on prescription medications
redeemed within 180 days before the hospital admission, and classified patients as users/non-
users of anti-hypertensive medications, glucose-lowering medications, lipid-lowering medica-
tions, antidepressant or anxiolytic medications, prescription painkillers, inhalants for obstruc-
tive airway diseases, glucocorticoids, and medications for gastric disorders (see S5 Table for
codes).
Statistical analyses
We first ascertained the BMI distribution in the study population. We then tabulated demo-
graphic variables (sex and age), CCI score (none, moderate, or severe), number of admissions,
Body Mass Index, clinical characteristics and mortality among patients acutely admitted to Danish hospitals
PLOS ONE | https://doi.org/10.1371/journal.pone.0195853 April 16, 2018 3 / 16
hospital and department type, and smoking status (categorized as above). We calculated
30-day mortality proportions for each predefined BMI category and estimated mortality odds
ratios (ORs), using BMI 18.5 to<25 kg/m2 as reference category. We also calculated the OR
adjusted for age and smoking status (adjusted OR, aOR), to assess if associations with BMI
were independent of age and smoking. We refrained from further adjustments, as the order of
factors in the causal pathway is impossible to disentangle in a cross-sectional design; factors
such as comorbidities and medications may thus be mediators of any BMI effect on mortality
rather than confounders. We presented graphically the proportions of users of selected medi-
cations and important causes of admission by BMI category, and further tabulated hospital
contacts according to primary ICD-10 diagnosis chapters. We also calculated the prevalence
ratios of causes of admission, using BMI 18.5 to<25 kg/m2 as reference category.
Our study followed the RECORD guidelines,[34] and all data were fully anonymized before
we accessed them. The study was approved by the Danish Data Protection Agency (Record
Number KEA-2016-26). According to Danish legislation, registry-based studies do not require
separate approval from the Danish Scientific Ethics Committee, nor do they require a written
consent from the patients. The source data files were kept by the Central Denmark region and
only files with the needed variables were exported to the Department of Clinical Epidemiology
for research purposes. Only structured data were exported and the unique personal identifier
(the CPR number) were encrypted in all data files. Personal variables like names, addresses etc.
were excluded in all data files before transmission. Patients did not provide a written consent
as the The Danish Act on Processing of Personal Data (Persondataloven) provides the legal
basis for the ability of public institutions, including universities, to retain person-identifiable
health data for research purposes. In addition, use of these data required a project-specific per-
mission from the Data Protection Agency (Datatilsynet, www.datatilsynet.dk).
Results
BMI distribution in hospitalized patients
Among 92,027 acutely admitted patients (median age 62 years, 50.5% male), the BMI distribu-
tion was as follows: underweight: 4.0%, normal weight: 41.8%, overweight: 33.8%, obesity class
I: 13.9%, obesity class II: 4.4%, and obesity class III: 2.1% (Table 1).
Mortality
Overall 30-day mortality was 2.3%. Compared with normal-weight patients (30-day mortality
2.8%), underweight patients had the highest 30-day mortality (7.5%, aOR: 2.37 (95% CI; 1.95–
2.89)) and patients with overweight (aORs: 0.65 (95% CI; 0.56–0.76), and in obesity classes I
and II had the lowest 30-day mortality (1.4%, aORs: 0.76 (95% CI; 0.61–0.94), and 0.86 (95%
CI; 0.59–1.26), with crude differences diminishing substantially after adjustment for age and
smoking differences (Fig 1, Table 2).
Reasons for admission
Overall, reasons for acute hospital admission differed substantially by BMI range (Fig 2, Tables
3 and 4, and S2 Table).
Compared with normal-weight individuals as reference (20.4%, Table 2), we observed large
differences in the proportion of admissions due to diseases of the circulatory system among
patients with underweight: 14.5%, PR: 0.7 (95% CI; 0.7–0.8), overweight: 26.4%, PR: 1.3 (95%
CI; 1.3–1.4), and obesity class III: 22.8%, PR: 1.1 (95% CI; 1.0–1.2)). Patients with normal
weight had a high frequency of admissions due to injuries (e.g., fractures) and poisoning
Body Mass Index, clinical characteristics and mortality among patients acutely admitted to Danish hospitals
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Table 1. Characteristics of 92,027 patients acutely admitted to hospital in the Central Denmark Region between 2011 and 2014.
Total BMI<18.5
kg/m2
BMI 18.5 to 25
kg/m2
BMI 25 to 30
kg/m2
BMI 30 to 35
kg/m2
BMI 35 to 40
kg/m2
BMI > 40
kg/m2
Obesity, all,
BMI > 30 kg/m2
Overall: 92,027
(100)
3701 (100) 38,446 (100) 31,093 (100) 12,810 (100) 4048 (100) 1929 (100) 18,787 (100)
Sex
Female, n (%) 45,570
(49.5)
2709 (73.2) 21,001 (54.6) 12,682 (40.8) 5791 (45.2) 2213 (54.7) 1174
(60.9)
9178 (48.9)
Male, n (%) 46,457
(50.5)
992 (26.8) 17,445 (45.4) 18,411 (59.2) 7019 (54.8) 1835 (45.3) 755 (39.1) 9609 (51.1)
Age, median (interquartile range) 62 (45, 74) 68 (48, 81) 62 (42, 76) 63 (48,74) 61 (47, 71) 57 (44, 68) 54 (41, 66) 59 (40,73)
Age group, years
18–29, n (%) 9436 (10.3) 532 (14.4) 5421 (14.1) 2201 (7.1) 804 (6.3) 320 (7.9) 158 (8.2) 1282 (6.8)
30–39, n (%) 8251 (9) 198 (5.3) 3483 (9.1) 2604 (8.4) 1225 (9.6) 472 (11.7) 269 (13.9) 1966 (10.5)
40–49, n (%) 11,187
(12.2)
250 (6.8) 4039 (10.5) 3963 (12.7) 1839 (14.4) 697 (17.2) 399 (20.7) 2935 (15.6)
50–59, n (%) 14,087
(15.3)
402 (10.9) 5067 (13.2) 5097 (16.4) 2368 (18.5) 787 (19.4) 366 (19) 3521 (18.7)
60–69, n (%) 18,824
(20.5)
614 (16.6) 6854 (17.8) 6945 (22.3) 3016 (23.5) 964 (23.8) 431 (22.3) 4411 (23.5)
70–79, n (%) 16,822
(18.3)
691 (18.7) 6744 (17.5) 6190 (19.9) 2366 (18.5) 588 (14.5) 243 (12.6) 3197 (17.0)
80–89, n (%) 10,995
(11.9)
735 (19.9) 5441 (14.2) 3489 (11.2) 1070 (8.4) 200 (4.9) 60 (3.1) 1330 (7.1)
90–99, n (%) 2379 (2.6) 271 (7.3) 1372 (3.6) 592 (1.9) 121 (0.9) 20 (0.5) 3 (0.2) 144 (0.8)
100+, n (%) 46 (0) 8 (0.2) 25 (0.1) 12 (0) 1 (0) 0 (0) 0 (0) 1 (0)
CCI level
No comorbidity reported 163,554
(67.4)
2163 (58.4) 25580 (66.5) 20292 (65.3) 8409 (65.6) 2725 (67.3) 1279
(66.3)
12,413 (66.1)
Moderate comorbidity 62,875
(25.9)
1213 (32.8) 10373 (27) 9010 (29) 3605 (29.1) 1093 (27) 522 (27.1) 5220 (27.8)
Severe comorbidity 16,208
(6.7)
325 (8.8) 2493 (6.5) 1791 (5.8) 796 (6.2) 230 (5.7) 128 (6.6) 1154 (6.1)
Year
2011, n (%) 14,329
(15.6)
613 (16.6) 5806 (15.1) 4916 (15.8) 2031 (15.9) 661 (16.3) 302 (15.7) 2994 (15.9)
2012, n (%) 22,285
(24.2)
999 (27) 9285 (24.2) 7535 (24.2) 3016 (23.5) 1007 (24.9) 443 (23) 4466 (23.8)
2013, n (%) 26,807
(29.1)
1045 (28.2) 11,322 (29.4) 9068 (29.2) 3733 (29.1) 1120 (27.7) 519 (26.9) 5372 (28.6)
2014, n (%) 28,606
(31.1)
1044 (28.2) 12,033 (31.3) 9574 (30.8) 4030 (31.5) 1260 (31.1) 665 (34.5) 5955 (31.7)
Number of acute admissions
during 2011–2014
1, n (%) 50,565
(54.9)
1598 (43.2) 21,394 (55.6) 17,393 (55.9) 6973 (54.4) 2191 (54.1) 1016
(52.7)
10,180 (54.2)
2, n (%) 19,319 (21) 886 (23.9) 7828 (20.4) 6532 (21) 2764 (21.6) 886 (21.9) 423 (21.9) 4073 (21.7)
3, n (%) 8532 (9.3) 435 (11.8) 3511 (9.1) 2772 (8.9) 1227 (9.6) 418 (10.3) 169 (8.8) 1814 (9.7)
4, n (%) 4783 (5.2) 298 (8.1) 1970 (5.1) 1553 (5) 661 (5.2) 192 (4.7) 109 (5.7) 962 (5.1)
5–9, n (%) 7287 (7.9) 392 (10.6) 3136 (8.2) 2353 (7.6) 952 (7.4) 279 (6.9) 175 (9.1) 1406 (7.5)
10–19, n (%) 1401 (1.5) 80 (2.2) 565 (1.5) 444 (1.4) 204 (1.6) 73 (1.8) 35 (1.8) 312 (1.7)
20–29, n (%) 126 (0.1) 10 (0.3) 36 (0.1) 42 (0.1) 27 (0.2) 9 (0.2) 2 (0.1) 38 (0.2)
30+, n (%) 14 (0) 2 (0.1) 6 (0) 4 (0) 2 (0) 0 (0) 0 (0) 2 (0)
Hospital type
(Continued)
Body Mass Index, clinical characteristics and mortality among patients acutely admitted to Danish hospitals
PLOS ONE | https://doi.org/10.1371/journal.pone.0195853 April 16, 2018 5 / 16
(underweight: 17.5%, normal weight: 19.7%, overweight: 15.9%, and obesity class III: 13.7%)
(Table 3, see S1 Table for diagnosis codes). For respiratory diseases (e.g., COPD), we observed
a J-shaped association based on visual judgment, with the highest prevalence proportions
Table 1. (Continued)
Total BMI<18.5
kg/m2
BMI 18.5 to 25
kg/m2
BMI 25 to 30
kg/m2
BMI 30 to 35
kg/m2
BMI 35 to 40
kg/m2
BMI > 40
kg/m2
Obesity, all,
BMI > 30 kg/m2
Provincial hospital, n (%) 69,301
(75.3)
2747 (74.2) 28,248 (73.5) 23,605 (75.9) 9979 (77.9) 3166 (78.2) 1556
(80.7)
14,701 (78.3)
University hospital, n (%) 22,726
(24.7)
954 (25.8) 10,198 (26.5) 7488 (24.1) 2831 (22.1) 882 (21.8) 373 (19.3) 4086 (21.7)
Department type
Medical, n (%) 37,267
(40.5)
1533 (41.4) 15,069 (39.2) 13,017 (41.9) 5245 (40.9) 1640 (40.5) 763 (39.6) 7648 (40.7)
Acute, n (%) 26,843
(29.2)
1118 (30.2) 10,830 (28.2) 9025 (29.0) 3954 (30.9) 1262 (31.2) 654 (33.9) 5870 (31.2)
Surgical, n (%) 24,799
(26.9)
922 (24.9) 10,968 (28.5) 8186 (26.3) 3259 (25.4) 1015 (25.1) 449 (23.3) 4723 (25.1)
Other, n (%) 3118 (3.4) 128 (3.5) 1579 (4.1) 865 (2.8) 352 (2.7) 131 (3.2) 63 (3.3) 546 (2.9)
Smoking status
Missing, n (%) 37,634
(40.9)
1634 (44.2) 16024 (41.7) 12518 (40.3) 5120 (40.0) 1576 (38.9) 762 (39.5) 7458 (39.7)
Available smoking status 54,393
(59.1)
2067 (55.8) 22422 (58.3) 18575 (59.7) 7690 (60.0) 2472 (61.1) 1167
(60.5)
11,329 (60.3)
Never smoker, n (%) 20,499
(37.7)
540 (26.1) 8521 (38.0) 7065 (38.0) 2876 (37.4) 1013 (41.0) 484 (41.5) 4373 (38.6)
Former smoker, n (%) 16,131
(29.7)
461 (22.3) 5805 (25.9) 6097 (32.8) 2649 (34.4) 753 (29.7) 366 (31.4) 3768 (33.3)
Daily smoker, n (%) 14,738
(27.1)
938 (45.4) 6711 (29.9) 4399 (23.7) 1810 (23.5) 610 (24.7) 270 (23.1) 2690 (23.7)
Occasional smoker, n (%) 3025 (5.6) 128 (6.2) 1385 (6.2) 735 (4.0) 355 (4.6) 96 (3.9) 47 (4.0) 498 (4.4)
https://doi.org/10.1371/journal.pone.0195853.t001
Fig 1. 30-day mortality among patients acutely admitted, by BMI category.
https://doi.org/10.1371/journal.pone.0195853.g001
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among patients with underweight (17.4%, PR: 2.0 (95% CI; 1.8–2.1)) and among patients in
obesity class III (9.9%, PR: 1.1 (95% CI; 1.0–1.3)) (Tables 3 and 4). Other diseases, including
diseases of the digestive system or “symptoms, signs and abnormal clinical findings” had simi-
lar frequencies according to BMI category. For several specific conditions within these disease
categories, findings were comparable (see Fig 2 and description below).
Patients with underweight
Patients with underweight differed substantially from patients in the other BMI categories.
Median age was high [68 years (IQR: 48–81 years)]; 26.8% were male; many patients smoked
daily (45.4%); and 41.6% had previous hospital-diagnosed comorbidities (Table 1). Admis-
sions due to respiratory diseases were more frequent than in the other BMI categories: chronic
obstructive pulmonary disease accounted for 6.0% of admissions, pneumonia: 4.5%, pneumo-
nia: 3.8%, bacterial pneumonia for 2.0%, respiratory failure for 1.8%, acute lower respiratory
infection for 1.7%, and fracture of the femur for 6.8% (Fig 2, S2 Table).
Among underweight patients, 38.0% were prescribed painkillers, 38.1% used antibiotic
medications, 23.0% used antidepressant and anxiolytic medications; 20.1% used inhalants for
obstructive airway diseases, 18.1% used drugs to treat gastric acid-related diseases, and 11.7%
used glucocorticoids (Fig 3, S6 Table).
Table 2. Mortality odds ratios (ORs), using normal weight as reference.
30-day mortality, % OR (95% CI) OR (95% CI)
Adjusted for age
OR (95% CI)
Adjusted for age and smoking
BMI <18.5 kg/m2 7.5 2.81 (2.45–3.22) 2.17 (1.89–2.51) 2.37 (1.95–2.89)
BMI 18.5 to 25 kg/m2 2.8 Ref. Ref. Ref.
BMI 25 to 30 kg/m2 1.6 0.56 (0.51–0.63) 0.61 (0.55–0.68) 0.65 (0.56–0.76)
BMI 30 to 35 kg/m2 1.4 0.50 (0.43–0.58) 0.63 (0.54–0.74) 0.76 (0.61–0.94)
BMI 35 to 40 kg/m2 1.4 0.50 (0.38–0.65) 0.80 (0.61–1.05) 0.86 (0.59–1.26)
BMI > 40 kg/m2 1.7 0.58 (0.41–0.83) 1.12 (0.78–1.60) 1.08 (0.64–1.82)
https://doi.org/10.1371/journal.pone.0195853.t002
Fig 2. Selected reasons for acute inpatient admission (first-listed diagnosis codes), by BMI category.
https://doi.org/10.1371/journal.pone.0195853.g002
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Patients with normal weight
Among patients with normal weight, the median age was 62 years (IQR: 42–76 years), 45.4%
were male, 66.5% had no comorbidities, 29.9% smoked daily, and 30-day mortality was 2.8%
(Table 1). The three most common causes of hospital admission were abdominal and pelvic
pain (5.3%), fracture of femur (4.2%), and atrial fibrillation and flutter (3.3%) (Fig 2 and S2
Table). Among patients with normal weight, 68.9% were users of any medication (Fig 3, S6
Table).
Patients with overweight
Among overweight patients, the median age was 63 years (IQR: 48–74 years), 59.2% were
male, 65.3% had no comorbidities, 23.7% smoked daily, and 30-day mortality was 1.6%
(Table 1). Admission patterns were similar to those of patients with normal weight. However,
prevalence of cholelithiasis was higher (1.8%) (Fig 1 and S2 Table). The overall prevalence of
medication use was 72.9% (Fig 3, S6 Table). The use of antibiotic medications (28.7%), antide-
pressants and anxiolytic medications (16.0%), glucocorticoids (10.5%), and inhalants for
obstructive airway diseases (10.5%) was lower than in the other BMI categories (Fig 3 and S6
Table).
Table 3. Primary discharge diagnosis codes according to ICD-10 chapters.
Disease category All patients
N = 92027
BMI <18.5
kg/m2
N = 3701
BMI 18.5 to 25
kg/m2
N = 38446
BMI 25 to 30
kg/m2
N = 31093
BMI 30 to 35
kg/m2
N = 12810
BMI 35 to 40
kg/m2
N = 4048
BMI > 40
kg/m2
N = 1929
Infectious diseases including pneumonia 3,510 (3.8) 154 (4.2) 1,437 (3.7) 1,090 (3.5) 498 (3.9) 200 (4.9) 131 (6.8)
Neoplasms 7,066 (7.7) 395 (10.7) 3,225 (8.4) 2,317 (7.5) 817 (6.4) 223 (5.5) 89 (4.6)
Hematological diseases 1,364 (1.5) 82 (2.2) 569 (1.5) 413 (1.3) 202 (1.6) 68 (1.7) 30 (1.6)
Endocrine, nutritional and metabolic disorders 4,817 (5.2) 245 (6.6) 1,790 (4.7) 1,384 (4.5) 805 (6.3) 346 (8.5) 247 (12.8)
Mental and behavioral disorders 868 (0.9) 65 (1.8) 413 (1.1) 254 (0.8) 101 (0.8) 26 (0.6) 9 (0.5)
Diseases of the nervous system 5,629 (6.1) 210 (5.7) 2,216 (5.8) 1,910 (6.1) 865 (6.8) 287 (7.1) 141 (7.3)
Diseases of the eye and adnexa 2,520 (2.7) 103 (2.8) 1,024 (2.7) 822 (2.6) 367 (2.9) 129 (3.2) 75 (3.9)
Diseases of the ear and mastoid process 1,527 (1.7) 58 (1.6) 654 (1.7) 538 (1.7) 193 (1.5) 63 (1.6) 21 (1.1)
Diseases of the circulatory system 21,543
(23.4)
536 (14.5) 7,827 (20.4) 8,208 (26.4) 3,487 (27.2) 1,045 (25.8) 440 (22.8)
Diseases of the respiratory system 7,740 (8.4) 645 (17.4) 3,369 (8.8) 2,233 (7.2) 965 (7.5) 337 (8.3) 191 (9.9)
Diseases of the digestive system 11,666
(12.7)
441 (11.9) 4,700 (12.2) 3,975 (12.8) 1,759 (13.7) 527 (13.0) 264 (13.7)
Diseases of the skin and subcutaneous tissue 2,774 (3.0) 65 (1.8) 989 (2.6) 978 (3.1) 466 (3.6) 179 (4.4) 97 (5.0)
Diseases of the musculoskeletal system and
connective tissue
6,855 (7.4) 246 (6.6) 2,686 (7.0) 2,366 (7.6) 1,051 (8.2) 355 (8.8) 151 (7.8)
Diseases of the genitourinary system 5,910 (6.4) 219 (5.9) 2,486 (6.5) 1,945 (6.3) 817 (6.4) 288 (7.1) 155 (8.0)
Pregnancy, childbirth and the puerperium 1,319 (1.4) 36 (1.0) 693 (1.8) 331 (1.1) 154 (1.2) 67 (1.7) 38 (2.0)
Conditions originating in the perinatal period 3 (0.0) 0 (0.0) 1 (0.0) 2 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Congenital malformations, deformations and
chromosomal abnormalities
352 (0.4) 23 (0.6) 167 (0.4) 88 (0.3) 47 (0.4) 21 (0.5) 6 (0.3)
Symptoms, signs and abnormal clinical and
laboratory findings
16,272
(17.7)
658 (17.8) 6,857 (17.8) 5,444 (17.5) 2,285 (17.8) 707 (17.5) 321 (16.6)
Injury and poisoning 15,822
(17.2)
646 (17.5) 7,556 (19.7) 4,946 (15.9) 1,860 (14.5) 549 (13.6) 265 (13.7)
External causes of morbidity and mortality 34 (0.0) 4 (0.1) 11 (0.0) 14 (0.0) 4 (0.0) 1 (0.0) 0 (0.0)
https://doi.org/10.1371/journal.pone.0195853.t003
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Table 4. Prevalence ratios (PRs) of discharge diagnosis codes according to ICD-10 chapters.
Disease category BMI <18.5
kg/m2
N = 3701
BMI 18.5 to 25
kg/m2
N = 38446
BMI 25 to 30
kg/m2
N = 31093
BMI 30 to 35
kg/m2
N = 12810
BMI 35 to 40
kg/m2
N = 4048
BMI > 40 kg/m2
N = 1929
Infectious diseases including pneumonia 1.1 (0.9–1.3) Ref. 0.9 (0.9–1.0) 1.0 (0.9–1.1) 1.3 (1.1–1.5) 1.8 (1.5–2.2)
Neoplasms 1.3 (1.2–1.4) Ref. 0.9 (0.8–0.9) 0.8 (0.7–0.8) 0.7 (0.6–0.7) 0.6 (0.4–0.7)
Hematological diseases 1.5 (1.2–1.9) Ref. 0.9 (0.8–1.0) 1.1 (0.9–1.2) 1.1 (0.9–1.5) 1.1 (0.7–1.5)
Endocrine, nutritional and metabolic disorders 1.4 (1.2–1.6) Ref. 1.0 (0.9–1.0) 1.3 (1.2–1.5) 1.8 (1.6–2.1) 2.8 (2.4–3.1)
Mental and behavioral disorders 1.6 (1.3–2.1) Ref. 0.8 (0.7–0.9) 0.7 (0.6–0.9) 0.6 (0.4–0.9) 0.4 (0.2–0.8)
Diseases of the nervous system 1.0 (0.9–1.1) Ref. 1.1 (1.0–1.1) 1.2 (1.1–1.3) 1.2 (1.1–1.4) 1.3 (1.1–1.5)
Diseases of the eye and adnexa 1.0 (0.9–1.3) Ref. 1.0 (0.9–1.1) 1.1 (1.0–1.2) 1.2 (1.0–1.4) 1.5 (1.2–1.8)
Diseases of the ear and mastoid process 0.9 (0.7–1.2) Ref. 1.0 (0.9–1.1) 0.9 (0.8–1.0) 0.9 (0.7–1.2) 0.6 (0.4–1.0)
Diseases of the circulatory system 0.7 (0.7–0.8) Ref. 1.3 (1.3–1.3) 1.3 (1.3–1.4) 1.3 (1.2–1.3) 1.1 (1.0–1.2)
Diseases of the respiratory system 2.0 (1.8–2.1) Ref. 0.8 (0.8–0.9) 0.9 (0.8–0.9) 1.0 (0.9–1.1) 1.1 (1.0–1.3)
Diseases of the digestive system 1.0 (0.9–1.1) Ref. 1.0 (1.0–1.1) 1.1 (1.1–1.2) 1.1 (1.0–1.2) 1.1 (1.0–1.3)
Diseases of the skin and subcutaneous tissue 0.7 (0.5–0.9) Ref. 1.2 (1.1–1.3) 1.4 (1.3–1.6) 1.7 (1.5–2.0) 2.0 (1.6–2.4)
Diseases of the musculoskeletal system and connective tissue 1.0 (0.8–1.1) Ref. 1.1 (1.0–1.1) 1.2 (1.1–1.3) 1.3 (1.1–1.4) 1.1 (1.0–1.3)
Diseases of the genitourinary system 0.9 (0.8–1.0) Ref. 1.0 (0.9–1.0) 1.0 (0.9–1.1) 1.1 (1.0–1.2) 1.2 (1.1–1.5)
Pregnancy, childbirth and the puerperium 0.5 (0.4–0.8) Ref. 0.6 (0.5–0.7) 0.7 (0.6–0.8) 0.9 (0.7–1.2) 1.1 (0.8–1.5)
Conditions originating in the perinatal period 0.0 (.-.) Ref. 2.5 (0.2–
27.3)
0.0 (.-.) 0.0 (.-.) 0.0 (.-.)
Congenital malformations, deformations and chromosomal
abnormalities
1.4 (0.9–2.2) Ref. 0.7 (0.5–0.8) 0.8 (0.6–1.2) 1.2 (0.8–1.9) 0.7 (0.3–1.6)
Symptoms, signs and abnormal clinical and laboratory findings 1.0 (0.9–1.1) Ref. 1.0 (1.0–1.0) 1.0 (1.0–1.0) 1.0 (0.9–1.1) 0.9 (0.8–1.0)
Injury and poisoning 0.9 (0.8–1.0) Ref. 0.8 (0.8–0.8) 0.7 (0.7–0.8) 0.7 (0.6–0.7) 0.7 (0.6–0.8)
External causes of morbidity and mortality 3.8 (1.2–
11.9)
Ref. 1.6 (0.7–3.5) 1.1 (0.3–3.4) 0.9 (0.1–6.7) 0.0 (.-.)
https://doi.org/10.1371/journal.pone.0195853.t004
Fig 3. Current use of selected prescription drugs, by BMI category.
https://doi.org/10.1371/journal.pone.0195853.g003
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Patients with obesity
Patients with BMI30 were relatively young (59 years median), few patients smoked (24%),
and 66.1% had no comorbidities.
The median age varied from 61 in obesity class I to 54 years in obesity class III (Table 1).
Male gender accounted for 39.1%-54.8% of persons in obesity classes I-III. Thirty-day mortal-
ity was lower among patients in obesity classes I and II (1.4%), compared to 1.7% among
patients in obesity class III. Patients with obesity had a high overall prevalence of medication
use: 78.1% in class I, 81.8% in class II, and 83.6% in class III (Fig 3 and S6 Table). This included
a high prevalence of users of glucose-lowering medications (14.9% to 23.6%), antihypertensive
medications (21.5% to 21.5%), lipid-lowering medications (30.9% to 29.2%), and antibiotic
medications (31.2% to 39.1%). Hospital admissions due to type 2 diabetes increased with
higher BMI (obesity class I: 2.6%, obesity class II: 3.6%, and obesity class III: 6.0%) (Fig 3 and
S2 Table). Other common causes of hospitalization were cholelithiasis (2.5% to 2.7%), sleep
disorders (1.3% to 3.2%), breathing abnormalities (1.3% to 2.4%), erysipelas (1.1% to 3.5%),
cutaneous abscess, furuncle, and carbuncle (1.5% to 2.2%) and heart failure (1.6% to 2.0%).
Discussion
To our knowledge, this is the first study to examine BMI distribution among patients acutely
admitted to general hospitals in a setting with universal hospital coverage. This contrasts with
previous studies which have examined BMI and mortality either in general populations of
adults [3,5] or among patients with specific diseases or inclusion criteria.[6–11]
When comparing our 92,027 hospitalized patients with Denmark’s general population, a
recent BMI survey in 2017 found that 2.7% of the Danish population had a self-reported BMI
<18.5 kg/m2, 47.4% had BMI25 kg/m2, and 14.1% had BMI30 kg/m2.[35] The corre-
sponding numbers for our hospitalized cohort of 2.4%, 51.0%, and 16.8%, respectively, indi-
cate a slight overrepresentation of patients with high BMI values. This may reflect a truly
increased admission rate in underweight or overweight people, or alternatively, more complete
BMI recording among hospitalized patients with high BMI.
Overall, we observed considerable differences in patient characteristics and causes of
admissions according to BMI category. In line with previous studies on patients with acute
admissions,[6–11] we found that patients with underweight had the highest 30-day mortality,
while patients in obesity classes I and II had the lowest 30-day mortality, apparently related in
part to their lower median age. Compared to patients with normal weight or obesity, patients
with underweight were older, and more likely to be female, to have more comorbidities and
more abnormal blood test results, and to have a higher prevalence of medication use and
smoking. In contrast, patients with obesity were younger, had a lower frequency of smoking
and lower use of several types of drugs, including antibiotic drugs and inhalants for obstructive
airway diseases, but many more metabolic-syndrome-related risk factors.
It has been suggested that the higher mortality among patients with underweight in previ-
ous studies may be explained in part by an association between low BMI, tobacco smoking,
and underlying illness leading to non-intentional weight loss. In contrast, our observation of a
lower mortality in patients with overweight or obesity as compared with normal weight
patients even after controlling for differences in age and smoking seems to confirm the ‘obesity
paradox’. [6–11,36] Importantly, we found that patients with normal weight, overweight, and
obesity were very similar with regards to both age distribution, comorbidity, and history of
ever smoking. Obesity is associated with proinflammatory defenses and increased energy
reserves, which may be protective in patients with acute or chronic disease.[37,38] Some stud-
ies have reported an age-associated protective effect of overweight on mortality: the higher the
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age, the more protective is the effect of overweight on mortality.[36] Alternatively, a previous
study suggested that a higher proportion of people with obesity may be admitted to hospital,
despite similar or lower severity of illness as compared with normal weight individuals.[10]
Any lowered admission threshold may cause surveillance bias and lead to underestimation of
mortality in obese patients. Another possible explanation on the obesity paradox is the pres-
ence of “collider bias”: a situation, where uncorrelated causes [e.g, obesity and infections] “col-
lide” by each competing to trigger the same outcome [e.g. heart failure]–and in the cases
where obesity is the cause, the course of the disease may be more mild than in the cases where
other causes lead to the disease [eg. infectious cardiomyopathy].[39]
We found a close association between underweight and specific chronic conditions, includ-
ing chronic pulmonary disease (COPD). Tobacco smoking, [5,26,27] known to have a great
impact on disease patterns and mortality, was also more prevalent among underweight per-
sons. These findings corroborate findings in previous cross sectional studies, in which smok-
ing has been related to both underweight [40] and COPD [27] and COPD patients were more
underweight than people without COPD.[41] Hospital admissions due to pneumonia also
were frequent among patients with underweight, in line with a recent meta-analysis
(N = 2,561,839 patients) that reported a relative risk of 1.8 of for community-acquired pneu-
monia among patients with underweight compared to patients with normal weight.[42] We
found that fractures of the femur also were common among patients with underweight corrob-
orating previous findings.[43] Underweight is a documented risk factor for osteoporotic frac-
tures.[44] Although the mechanisms through which low BMI may affect bone mineral density
are not completely understood, the low levels of hormones secreted in the adipose tissue,
including estrogen, leptin, and interleukin-6, may be protective.[21,45] Smoking is associated
with low BMI,[40] low bone mineral density,[46] and fracture risk,[20] and likely contributed
to the high number of observed fracture admissions.[21,45]
Corroborating others’ findings, [28] hospital admissions due to type 2 diabetes and use of
drugs to treat metabolic syndrome-related diseases were common among patients with over-
weight and admissions due to type 2 diabetes and use of glucose-lowering drugs increased
with increasing BMI (Figs 2 and 3).[28] Cholelithiasis is also associated with obesity and the
metabolic syndrome.[31] As seen in Fig 2, our results confirm the well-known association
between obesity and obstructive sleep apnea.[47] Also infections including pneumonia and
erysipelas increased with increasing BMI (Fig 2), pointing to an association between obesity
and skin, wound, respiratory, and other infections, and overall use of antibiotics which is in
line with previous studies.[24,25,29,48–51] In contrast to previous findings, we found no clear
association between atrial fibrillation and BMI.[23]
The gender distribution differed among the BMI groups: both among patients with under-
weight and severe obesity, there was a high proportion of females, which may affect the disease
risk for e.g. angina pectoris.[52] Further studies are required to investigate the interaction
between obesity outcomes and gender in more detail.
Strengths and limitations
The main strengths of the present study include its unique information on BMI on a very large
sample size and the access to complete hospitalization and prescription records.
Our study has several potential limitations. Only 38% of all acutely admitted patients had
their BMI measured, and BMI values are likely not missing completely at random. Health care
professionals may have an inclination to weigh people with either very low or high BMI com-
pared with patients with normal BMI. Thus, since our data are likely not a random sample of
all acutely admitted patients, they cannot be used as an estimation for the BMI distribution of
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hospital admitted patients in general. However, we present data mostly stratified, and we may
argue that within strata of BMI, missingness is at random, and that data per strata (for exam-
ple, mortality) are not largely invalidated by missingness. Still information bias may have
occurred if, theoretically, a larger proportion of critically versus non-critically ill patients with
low BMI have their weight measured, while in patients with obesity, both critically and non-
critically ill patients may have their BMI measured.
Although inaccurate diagnostic coding may be a concern for the patient characteristics we
measured, the physician-coded diagnoses in the DNPR have been reported to be highly valid
for many conditions.[14] Concerning prescriptions, the AUPD contains data on prescriptions
filled,[19] but no information on actual medication intake. However, several studies have
shown good agreement between self-reported medication use or medication use reported by
general practitioners and prescriptions filled at pharmacies.[53–55] Finally, data on smoking
status relied on information self-reported by patients to their physicians, as recorded in the
Central Denmark Region clinical information system at time of admission, and patients may
underreport their smoking behavior. However, we assume that this possible underreporting is
non-differentially associated with BMI values.
Conclusion
We have profiled acutely hospitalized patients in Denmark by their BMI. We documented a
high short-term mortality among patients with underweight, however, we found evidence that
clinical characteristics differ substantially by BMI category in hospitalized patients. Patients
with underweight have a notably high frequency of smoking, admissions due to respiratory
diseases, osteoporotic fractures, and comorbidity. Patients with obesity are often hospitalized
due to skin infections, cholelithiasis, sleep disorders, diabetes, and heart failure. These data
may prove valuable for future studies on the prognostic effect of BMI following hospital admis-
sion for a range of diseases.
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